NCT07244068 Effect of Mat Pilates on Pain and Postural Alignment in School Going Children With Upper Crossed Syndrome.
| NCT ID | NCT07244068 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Children, Only |
| Study Type | INTERVENTIONAL |
| Enrollment | 28 participants |
| Start Date | 2025-10-28 |
| Primary Completion | 2026-06-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 28 participants in total. It began in 2025-10-28 with a primary completion date of 2026-06-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized control clinical Trial is to evaluate the effect of mat Pilates on postural alignment and pain levels in school-going children with Upper Crossed Syndrome. The study will focus on assessing changes in head, neck, and shoulder alignment, as well as any reduction in musculoskeletal discomfort following a structured Pilates intervention in children of age 8-16.This clinical Trial will be in two groups A) Intervention group B) Control Group. From a total of 28 Participants , 14 will be performing Mat pilates and routine Physical Therapy(Group A) while the other 14 will be performing just routine Physical Therapy exercises (Group B). Data Analysis will be done on Statistical Package for the Social Sciences (SPSS) version 26.00.
Eligibility Criteria
Inclusion Criteria: * School going children * Children of the age 8-16. * Children having Thoracic Kyphosis angle under 20° and over 40 °,and Craniovertebral angle under 48° Exclusion Criteria: * Children with systemic disorders. * Children with recent history of injury. * Physical or sensory defecit(16)
Contact & Investigator
Musfera Iqbal, MS-PT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07244068 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 16 Years, studying Children, Only. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07244068 currently recruiting?
Yes, NCT07244068 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07244068 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07244068 clinical trial?
NCT07244068 is sponsored by Riphah International University. The principal investigator is Musfera Iqbal, MS-PT at Riphah International University. The trial plans to enroll 28 participants.